Weaning From Mechanical Ventilation After Pediatric Cardiac Surgery
Launched by ALEXANDRIA UNIVERSITY · Jul 14, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the process of safely taking children off mechanical breathing machines after heart surgery. After surgery to fix heart problems, many children need help breathing through a machine, but doctors want to remove this support as soon as it’s safe. The study focuses on finding the best way to do this quickly and safely, because staying on the breathing machine longer than needed can lead to complications like lung infections or injury to the airway.
Children aged 2 to 10 years who have had heart surgery and meet certain health checks—like breathing with less machine support, having good oxygen levels, and being pain-free—might be eligible to join. However, children who have been on a breathing machine for more than two days, are unstable, have low consciousness, or have certain types of heart surgeries won’t be able to participate. If a child joins the study, their medical team will carefully watch how they are taken off the breathing machine to help speed up recovery while keeping them safe. This trial hasn’t started recruiting yet but aims to improve care for kids recovering from heart surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 2-10years.
- • 2. Both sex.
- • 3. after fulfilling weaning criteria
- • 4. being pain free (observational pain/discomfort scale \< 4). the weaning criteria; which include: low mandatory ventilator rate \[6-8\] or less; fraction of inspired oxygen (FIO2) ≤ 40; level of positive end expiratory pressure (PEEP) \[3-5 cmH2O\] guided by pressure/volume loop; reversal of the cause of postoperative mechanical ventilation; oxygenation index (OI) (mean air way pressure × FIO2/PaO2) \< 5; dynamic compliance (Cdyn) \> 1 ml/ cmH2O/kg
- Exclusion Criteria:
- • 1. Duration of mechanical ventilation is more than 48 hours
- • 2. Patients on high inotropic support (unstable hemodynamics)
- • 3. Patients with disturbed conscious level
- • 4. Patients with palliative cardiac shunting procedures (e.g., BT shunt, Glenn shunt).
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
LECTURER OF ANESTHESIA AND SURGICAL INTENSIVE CARE, Dr
Principal Investigator
University of Alexandria
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported